Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1
Synovial sarcoma is an aggressive mesenchymal tumor, characterized by the presence of unique transfusion gene, SS18–SSX. Cell lines enable researchers to investigate the molecular backgrounds of disease and the significance of SS18–SSX in relevant cellular contexts. We report the establishment and proteomic characterization of a novel synovial sarcoma cell line. Primary tissue culture was performed using tumor tissue of synovial sarcoma. The established cell line was authenticated by assessing its DNA microsatellite short tandem repeat analysis and characterized by in vitro assay. Proteomic study was achieved by mass spectrometry, and the results were analyzed by treemap. The cell line NCC-SS2-C1 was established from a primary tumor tissue of a synovial sarcoma patient. The cell line has grown well for 11 mo and has been subcultured more than 15 times. The established cells were authenticated by assessing their short tandem repeat pattern comparing with that of original tumor tissue. The cells showed polygonal in shape and formed spheroid when seeded on the low-attachment dish. Proteomic analysis revealed the molecular pathways which are unique to the original tumor tissue or the established cell line. In conclusion, a novel synovial sarcoma cell line NCC-SS2-C1 was successfully established from the primary tumor tissue. The cell line has characteristic transfusion SS18–SSX and poses aggressive in vitro growth and capability of spheroid formation. Thus, NCC-SS2-C1 cell line will be a useful tool for investigation of the mechanisms of disease and the biological role of fusion gene.
KeywordsSynovial sarcoma Fusion gene Cell line Proteome
We thank Drs. Y. Minami, K. Shimizu, T. Mori, T. Uehara, M. Sugawara, Y. Araki, and Ms. R. Nakano (Division of Musculoskeletal Oncology, National Cancer Center Hospital) for sampling tumor tissue specimens from surgically resected materials. We would also like to thank Editage (www.editage.jp) for English language editing and constructive comments on the manuscript.
RO and TK prepared the manuscript. ST, ME, AY, and AK were involved in the analysis of the clinical and pathological data. RO, FK, MS, KS, and YT conducted the study. All authors read and approved the final manuscript.
Compliance with ethical standards
Ethics approval and consent to participate
This study was approved by the ethical committee of the National Cancer Center, and the patient in this study provided written informed consent.
Consent for publication
The authors declare that they have no competing interests.
- Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehar J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, Morais P, Meltzer J, Korejwa A, Jane-Valbuena J, Mapa FA, Thibault J, Bric-Furlong E, Raman P, Shipway A, Engels IH, Cheng J, Yu GK, Yu J, Aspesi P Jr, de Silva M, Jagtap K, Jones MD, Wang L, Hatton C, Palescandolo E, Gupta S, Mahan S, Sougnez C, Onofrio RC, Liefeld T, MacConaill L, Winckler W, Reich M, Li N, Mesirov JP, Gabriel SB, Getz G, Ardlie K, Chan V, Myer VE, Weber BL, Porter J, Warmuth M, Finan P, Harris JL, Meyerson M, Golub TR, Morrissey MP, Sellers WR, Schlegel R, Garraway LA (2012) The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483(7391):603–607. https://doi.org/10.1038/nature11003 CrossRefPubMedPubMedCentralGoogle Scholar
- Billings SD, Meisner LF, Cummings OW, Tejada E (2000) Synovial sarcoma of the upper digestive tract: a report of two cases with demonstration of the X;18 translocation by fluorescence in situ hybridization. Mod Pathol 13(1):68–76. https://doi.org/10.1038/modpathol.3880011 CrossRefPubMedGoogle Scholar
- Bozzi F, Ferrari A, Negri T, Conca E, Luca da R, Losa M, Casieri P, Orsenigo M, Lampis A, Meazza C, Casanova M, Pierotti MA, Tamborini E, Pilotti S (2008) Molecular characterization of synovial sarcoma in children and adolescents: evidence of Akt activation. Transl Oncol 1(2):95–101. https://doi.org/10.1593/tlo.08121 CrossRefPubMedPubMedCentralGoogle Scholar
- dos Santos NR, de Bruijn DR, van Kessel AG (2001) Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer 30(1):1–14. https://doi.org/10.1002/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G CrossRefPubMedGoogle Scholar
- Herzog CE (2005) Overview of sarcomas in the adolescent and young adult population. J Pediatr Hematol Oncol 27(4):215–218. https://doi.org/10.1097/01.mph.0000161762.53175.e4 CrossRefPubMedGoogle Scholar
- Horvai AE, Kramer MJ, O'Donnell R (2006) Beta-catenin nuclear expression correlates with cyclin D1 expression in primary and metastatic synovial sarcoma: a tissue microarray study. Arch Pathol Lab Med 130(6):792–798. https://doi.org/10.1043/1543-2165(2006)130[792:CNECWC]2.0.CO;2Google Scholar
- Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR, Shima Y, Nagayama S, Katagiri T, Nakamura Y, Nakamura T, Toguchida J (2005) Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Clin Cancer Res 11(7):2702–2712. https://doi.org/10.1158/1078-0432.CCR-04-2057 CrossRefPubMedGoogle Scholar
- Kondo T, Hirohashi S (2007) Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat Protoc 1(6):2940–2956. https://doi.org/10.1038/nprot.2006.421 CrossRefGoogle Scholar
- Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JS, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O (2002) Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 62(1):135–140PubMedGoogle Scholar
- Mancuso T, Mezzelani A, Riva C, Fabbri A, Dal Bo L, Sampietro G, Perego P, Casali P, Zunino F, Sozzi G, Pierotti MA, Pilotti S (2000) Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma. Lab Investig 80(6):805–813. https://doi.org/10.1038/labinvest.3780085 CrossRefPubMedGoogle Scholar
- Raney RB (2005) Synovial sarcoma in young people: background, prognostic factors, and therapeutic questions. J Pediatr Hematol Oncol 27(4):207–211. https://doi.org/10.1097/01.mph.0000161764.60798.60 CrossRefPubMedGoogle Scholar
- Rees MG, Seashore-Ludlow B, Cheah JH, Adams DJ, Price EV, Gill S, Javaid S, Coletti ME, Jones VL, Bodycombe NE, Soule CK, Alexander B, Li A, Montgomery P, Kotz JD, Hon CS, Munoz B, Liefeld T, Dancik V, Haber DA, Clish CB, Bittker JA, Palmer M, Wagner BK, Clemons PA, Shamji AF, Schreiber SL (2016) Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat Chem Biol 12(2):109–116. https://doi.org/10.1038/nchembio.1986 CrossRefPubMedGoogle Scholar
- Sakumoto M, Takahashi M, Oyama R, Takai Y, Kito F, Shiozawa K, Qiao Z, Yoshida A, Endo M, Kawai A, Kondo T (2017) Establishment and proteomic characterization of NCC-LMS1-C1, a novel cell line of primary leiomyosarcoma in the bone. Jpn J Clin Oncol 47(10):954–961. https://doi.org/10.1093/jjco/hyx096 CrossRefPubMedGoogle Scholar
- Smith ME, Fisher C, Wilkinson LS, Edwards JC (1995) Synovial sarcoma lack synovial differentiation. Histopathology 26(3):279–281. https://doi.org/10.1111/j.1365-2559.1995.tb01444.x CrossRefPubMedGoogle Scholar
- Sun B, Sun Y, Wang J, Zhao X, Wang X, Hao X (2006) Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma. Eur J Cancer Prev 15(3):258–265. https://doi.org/10.1097/01.cej.0000198896.02185.68 CrossRefPubMedGoogle Scholar
- Weiss (2013) Enzinger and Weiss’s soft tissue tumors. Mosby Inc., St. LouisGoogle Scholar
- Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL (2003) Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 97(10):2530–2543. https://doi.org/10.1002/cncr.11365 CrossRefPubMedGoogle Scholar